Tuoxin Pharmaceutical announced that due to its own capital requirements, 1,461,600 Ontario companies, which hold more than 5% of the shares, reduced their holdings by a total of 850,000 shares through bulk transactions on the Shenzhen Stock Exchange from June 29, 2026 to September 7, 2026, accounting for 0.6717% of the company's total share capital, and the shareholding ratio was reduced from 13.7281% to 12.9973%. The current holdings reduction fulfils the previously disclosed holdings reduction plan.

Tuoxin Pharmaceutical announced that due to its own capital requirements, 1,461,600 Ontario companies, which hold more than 5% of the shares, reduced their holdings by a total of 850,000 shares through bulk transactions on the Shenzhen Stock Exchange from June 29, 2026 to September 7, 2026, accounting for 0.6717% of the company's total share capital, and the shareholding ratio was reduced from 13.7281% to 12.9973%. The current holdings reduction fulfils the previously disclosed holdings reduction plan.